Results
2
2 companies
Aelis Farma
Market Cap: €13.8m
A clinical-stage biopharmaceutical company, focuses on discovering and developing drug candidates for the treatment of central nervous system disorders in France.
AELIS
€1.02
7D
-11.7%
1Y
-82.8%
MaaT Pharma
Market Cap: €65.4m
A late-stage clinical company, engages in the development of gut microbiome-driven therapies to modulate the immune system and improve cancer survival.
MAAT
€4.06
7D
-9.2%
1Y
-44.7%